Sarcoma  >>  Oncophage (Heat Shock Protein Peptide Complex-96)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Oncophage (Heat Shock Protein Peptide Complex-96) / Agenus
NCT00005628: Vaccine Therapy in Treating Patients With Recurrent Soft Tissue Sarcoma

Completed
2
US
vitespen
Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI)
Sarcoma
08/01
08/01
NCT01814813: Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery

Checkmark Avastin + HSPPC-96 vs. Avastin alone in recurrent surgically resectable glioblatoma
Nov 2017 - Nov 2017: Avastin + HSPPC-96 vs. Avastin alone in recurrent surgically resectable glioblatoma
Terminated
2
90
US
HSPPC-96, bevacizumab
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), Agenus Inc.
Recurrent Glioblastoma, Recurrent Adult Brain Tumor, Gliosarcoma
04/17
05/23

Download Options